BSE filing, NSE: INFY. Summary written from the filing by ALFA Finder's alert engine.
Infosys Ltd: key numbers
- Share price
- ₹1,123.15
- Market cap
- ₹4,55,807 Cr
- Revenue (annual)
- ₹1,78,650 Cr
- Net profit (annual)
- ₹29,440 Cr
- P/E (TTM)
- 14.8×Sector 22.9×
- Promoter holding
- 13.90%+0.08% QoQ
- FII holding
- 27.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Infosys Ltd
All →Infosys Investor Presentation: Key Takeaways
Q2 FY27 revenue $5,145mn, +1.5% YoY cc; op margin 21%; FCF $928mn; AI 10.5% of revenue. FY27 revenue guidance cut to 1–2% cc from 1.5–3%.
Infosys Earnings Call Transcript: Key Takeaways
Q2 FY27 constant-currency revenue grew 1.5% YoY, below plan, and FY27 guidance was cut to 1-2% from 1.5-3%. Operating margin held at 21%; AI revenue reached 10.5% of sales, up 29% QoQ.
Infosys Business Update
Infosys announced the go-live of Syngenta's global SAP S/4HANA transformation for its Crop Protection business. The project supports over 10,000 employees across 80 countries.
Infosys Dividend
Infosys declared an interim dividend of Rs.26 per equity share on 23 October 2026. Record date is 3 November 2026, with payment by 11 November 2026.
Infosys Q2 FY27 Results: Net Profit ₹7,838 Cr, Up 6.3% YoY
Infosys Ltd reported revenue from operations of ₹49,244 Cr (+10.7% YoY) and net profit of ₹7,838 Cr (+6.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7,838 Cr · +6.3% YoY
Infosys Other Announcement
Infosys Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date